BPTH - Bio-Path Holdings, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
0
0
37
13
0
Cost of Revenue
-
-
-
-
0
Gross Profit
-
-
-
-
0
Operating Expenses
Research Development
4,765
4,603
5,480
5,474
3,020
Selling General and Administrative
3,628
3,379
3,523
3,014
2,464
Total Operating Expenses
8,393
7,982
9,003
8,488
5,484
Operating Income or Loss
-8,393
-7,982
-8,966
-8,475
-5,484
Interest Expense
-
-
-
-
-
Total Other Income/Expenses Net
-
-608
1,934
1,713
0
Income Before Tax
-8,958
-8,583
-7,023
-6,750
-5,467
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-8,958
-8,583
-7,023
-6,750
-5,467
Net Income
-8,958
-8,583
-7,023
-6,750
-5,467
Net Income available to common shareholders
-8,958
-8,583
-8,061
-6,750
-5,467
Reported EPS
Basic
-
-14.38
-16.00
-14.00
-12.00
Diluted
-
-14.38
-16.00
-14.00
-12.00
Weighted average shares outstanding
Basic
-
597
504
464
449
Diluted
-
597
504
464
449
EBITDA
-
-7,556
-8,555
-8,271
-5,283